| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EAF | Common Stock | Sale | -$195K | -93.8K | -0.32% | $2.08 | 28.8M | Dec 22, 2023 | See Explanation of Responses | F1, F2, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$195K | -94K | -0.33% | $2.08 | 28.7M | Dec 22, 2023 | See Explanation of Responses | F1, F2, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$347K | -167K | -0.58% | $2.08 | 28.5M | Dec 22, 2023 | See Explanation of Responses | F1, F2, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$17 | -8 | 0% | $2.08 | 28.5M | Dec 22, 2023 | See Explanation of Responses | F1, F2, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$13 | -6 | 0% | $2.08 | 28.5M | Dec 22, 2023 | See Explanation of Responses | F1, F2, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$182K | -86.4K | -0.3% | $2.11 | 28.4M | Dec 26, 2023 | See Explanation of Responses | F1, F3, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$182K | -86.6K | -0.3% | $2.11 | 28.4M | Dec 26, 2023 | See Explanation of Responses | F1, F3, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$324K | -154K | -0.54% | $2.11 | 28.2M | Dec 26, 2023 | See Explanation of Responses | F1, F3, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$15 | -7 | 0% | $2.11 | 28.2M | Dec 26, 2023 | See Explanation of Responses | F1, F3, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$13 | -6 | 0% | $2.11 | 28.2M | Dec 26, 2023 | See Explanation of Responses | F1, F3, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$235K | -111K | -0.39% | $2.12 | 28.1M | Dec 27, 2023 | See Explanation of Responses | F1, F4, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$235K | -111K | -0.4% | $2.12 | 28M | Dec 27, 2023 | See Explanation of Responses | F1, F4, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$418K | -197K | -0.71% | $2.12 | 27.8M | Dec 27, 2023 | See Explanation of Responses | F1, F4, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$19 | -9 | 0% | $2.12 | 27.8M | Dec 27, 2023 | See Explanation of Responses | F1, F4, F5, F6, F7, F8, F9, F10 |
| transaction | EAF | Common Stock | Sale | -$15 | -7 | 0% | $2.12 | 27.8M | Dec 27, 2023 | See Explanation of Responses | F1, F4, F5, F6, F7, F8, F9, F10 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 (the "Sales") were effected pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"). |
| F2 | On December 22, 2023, the Reporting Persons sold an aggregate of 550,000 shares of Common Stock. Represents (i) 93,807 of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 93,969 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 167,023 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 8 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 6 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 195,187 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. |
| F3 | On December 26, 2023, the Reporting Persons sold an aggregate of 506,800 shares of Common Stock. Represents (i) 86,439 shares of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 86,588 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 153,904 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 7 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 6 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 179,856 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. |
| F4 | On December 27, 2023, the Reporting Persons sold an aggregate of 650,000 shares of Common Stock. Represents (i) 110,863 shares of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 111,055 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 197,390 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 9 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 7 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 230,676 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. |
| F5 | Following the Sales, consists of (i) 7,346,505 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP and BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (ii) 7,359,249 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iii) 13,080,458 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; (iv) 624 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.; and (v) 480 shares of Common Stock held directly by BCP IV Bermuda Investor LP. |
| F6 | Brookfield Corporation ("BN"), by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares. |
| F7 | BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP. |
| F8 | Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BN, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BN, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P. |
| F9 | Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BN, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BCP IV Bermuda Investor LP. |
| F10 | Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. |
This Form 4 is being filed in three parts due to the number of Reporting Persons. All three Filings relate to the Sales described above in Table I. Part 3 of 3.